Rationalising medications through deprescribing
- PMID: 30733211
- DOI: 10.1136/bmj.l570
Rationalising medications through deprescribing
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare no other interests. Further details of The BMJ’s policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf. Provenance and peer review: Commissioned; not externally peer reviewed.
Comment in
- 
  
  A systematic approach to polypharmacy review.BMJ. 2019 Mar 11;364:l1034. doi: 10.1136/bmj.l1034. BMJ. 2019. PMID: 30858152 No abstract available.
Comment on
- 
  
  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.Br J Clin Pharmacol. 2015 Dec;80(6):1254-68. doi: 10.1111/bcp.12732. Br J Clin Pharmacol. 2015. PMID: 27006985 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
 
        